|
Real-time Estimate
Cboe BZX
22:35:34 23/10/2026 +03
|
5-day change | 1st Jan Change | ||
| 1.715 USD | -2.56% |
|
+26.10% | -85.93% |
| 10-08 | Tenax Therapeutics, Inc. Provides Update on Tnx-103 Level and Level-2 Clinical Trials | CI |
| 09-21 | Tenax Therapeutics, Inc.(NasdaqCM:TENX) added to S&P Global BMI Index | CI |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Sector Other Biotechnology & Medical Research
| Capi. | Sales Growth | Profitability | Finances | EV / Sales | P/E | |
|---|---|---|---|---|---|---|
 | 101M | - | - | - | - | - |
| 63.29B | |||||
| 54.89B | |||||
| 53.28B | |||||
| 45.81B | |||||
| 43.46B |
Select your edition
All financial news and data tailored to specific country editions
